Meningococcal Type B – A pharmacist’s guide to protecting patients against the most prevalent form of invasive meningococcal disease (IMD) in Canada

CAN-eng

$0

free

CCCEP

1 Hour

Infectious Disease

1.25 Credits

Course Description

Pharmacists play a key role in ensuring patients are educated about vaccines and are getting vaccinated against an increasing number of vaccine preventable diseases. Pharmacists have demonstrated that they can increase access and immunization rates against serious infections such as influenza. With the proper skillset, they can extend this success to other important immunizations for their patients.

This program will provide pharmacists with key information on meningococcal type B immunization. This infection is the most prevalent form of invasive meningococcal disease (IMD) in Canada. Although this infection is relatively rare, no other bacterial agent may kill as swiftly after bloodstream invasion as the meningococcus. It is crucial for pharmacists to be able to discuss the disease, its complications, the vaccine options, as well as, knowhow to integrate it into pharmacy practice.

Course Details

Expiry Date: 2021-07-15

Professions: Pharmacy

Faculty

Mark Awuku, MB, ChB, FRCP(C), FAAP, FGCP, LLD (Honoris Causa)

Nancy Waite, BScPhm, PharmD

Ajit Johal, BScPhm, ISTM

Accreditation

This continuing education lesson is designed primarily for pharmacists and has been accredited by the Canadian Council on Continuing Education in Pharmacy (CCCEP) for 1.25 CEUs.

Learning Objective(s)

Upon successful completion of this continuing education program, the pharmacist will be better able to:

  1. Describe
    meningococcal disease burden, epidemiology, disease significance & severity
  2. Review
    the challenges to MenB
    vaccine development, the indications and modes of action
  3. Highlight
    the growing body of scientific evidence supporting MenB
    vaccination e.g. real-world experience, dosing schedules, persistence data,
    immunogenicity data spanning the age cohorts at risk of disease
  4. Practical
    integration of non-publicly funded vaccines in the pharmacy: how to discuss MenB
    vaccination, targeting patients not seen as often by other healthcare
    professionals, practical vaccine administration considerations and how to
    address questions/concerns from parents/patients